{
  "CitationSubset": [],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "24611191",
  "DateCompleted": {
    "Year": "2014",
    "Month": "03",
    "Day": "11"
  },
  "DateRevised": {
    "Year": "2013",
    "Month": "09",
    "Day": "19"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "2153-8387",
      "JournalIssue": {
        "Volume": "19",
        "Issue": "9",
        "PubDate": {
          "Year": "2013",
          "Month": "Sep"
        }
      },
      "Title": "DukeMedicine healthnews",
      "ISOAbbreviation": "Duke Med Health News"
    },
    "ArticleTitle": "Possible new target for treating one of cancer's deadliest tumors. Researchers have identified an enzyme that may be the weak link in glioblastoma, a brain cancer that is resistant to most treatments.",
    "Pagination": {
      "StartPage": "7",
      "MedlinePgn": "7"
    },
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Duke Med Health News",
    "NlmUniqueID": "101510062",
    "ISSNLinking": "2153-8387"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "EC 2.7.1.107",
      "NameOfSubstance": "Diacylglycerol Kinase"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "enzymology",
        "therapy"
      ],
      "DescriptorName": "Brain Neoplasms"
    },
    {
      "QualifierName": [
        "antagonists & inhibitors",
        "physiology"
      ],
      "DescriptorName": "Diacylglycerol Kinase"
    },
    {
      "QualifierName": [
        "enzymology",
        "therapy"
      ],
      "DescriptorName": "Glioblastoma"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    }
  ]
}